Validation of the HAPPI Kids Continuous Age-Specific Pediatric Reference Intervals.


Journal

The journal of applied laboratory medicine
ISSN: 2576-9456
Titre abrégé: J Appl Lab Med
Pays: England
ID NLM: 101693884

Informations de publication

Date de publication:
01 11 2020
Historique:
received: 29 10 2019
accepted: 14 02 2020
pubmed: 17 7 2020
medline: 16 10 2021
entrez: 17 7 2020
Statut: ppublish

Résumé

To facilitate best possible patient care, reference intervals (RIs) adopted by a laboratory must be appropriate for the population demographics and, where applicable, the analytical principle and/or the analytical instrument used. While guidelines from the Clinical and Laboratory Standard Institute (CLSI) recommend a validation process for discrete RIs, there are no current recommendations for the validation process for continuous RIs. This study aimed to validate recently published, HAPPI Kids continuous RIs, in a routine laboratory. Initially, the difference in test results between the primary study laboratory that contributed to previous RIs development and a routine laboratory was assessed using specimens from 77 children tested in both laboratories using the Siemens ADVIA 1800 or Centaur/XP/XPT. Later, validation of the HAPPI Kids RIs was undertaken using 279 pediatric samples tested on the same analyzer type in the routine laboratory. The previously published RIs were validated if more than 90% of results in the routine laboratory were within the RIs. There was minimal evidence of clinically significant differences in test results between the primary and routine laboratories. The continuous RIs were validated after initial analysis for 16 of the 18 biochemistry analytes tested, and after secondary analysis for the remaining 2 analytes. This study validates the HAPPI Kids RIs in a routine laboratory, satisfying the laboratory accreditation requirements for evaluation, implementation, and sourcing of RIs. In addition, this study presents a modification of the current CLSI method for validation of continuous RIs that will benefit routine laboratories in general.

Identifiants

pubmed: 32674128
pii: 5822571
doi: 10.1093/jalm/jfaa045
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1337-1344

Informations de copyright

© American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Monsurul Hoq (M)

Murdoch Children's Research Institute, Parkville, Australia.
The University of Melbourne, Parkville, Australia.

Susan Matthews (S)

The Royal Children's Hospital, Parkville, Australia.
International Centre for Point of Care Testing, Flinders University, Bedford Park, Australia.

Vicky Karlaftis (V)

Murdoch Children's Research Institute, Parkville, Australia.

Janet Burgess (J)

The Royal Children's Hospital, Parkville, Australia.

Susan Donath (S)

Murdoch Children's Research Institute, Parkville, Australia.
The University of Melbourne, Parkville, Australia.

John Carlin (J)

Murdoch Children's Research Institute, Parkville, Australia.
The University of Melbourne, Parkville, Australia.

Vera Ignjatovic (V)

Murdoch Children's Research Institute, Parkville, Australia.
The University of Melbourne, Parkville, Australia.

Paul Monagle (P)

Murdoch Children's Research Institute, Parkville, Australia.
The University of Melbourne, Parkville, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH